IO Biotech News

IO Biotech Analyst Ratings

Benzinga11:22 ET

HC Wainwright & Co. Reiterates Buy on IO Biotech, Maintains $12 Price Target

Benzinga11:22 ET

Morgan Stanley Maintains IO Biotech(IOBT.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsNov 8 07:36 ET

H.C. Wainwright Maintains IO Biotech(IOBT.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsNov 8 07:35 ET

IO Biotech Receives Buy Rating Amid Promising Phase 2 Results and Future Potential in Cancer Treatments

TipRanksNov 6 06:28 ET

Jefferies Maintains IO Biotech(IOBT.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsOct 4 08:31 ET

IO Biotech Is Maintained at Overweight by Morgan Stanley

Dow JonesSep 16 07:55 ET

IO Biotech Analyst Ratings

BenzingaSep 16 07:28 ET

HC Wainwright & Co. Reiterates Buy on IO Biotech, Maintains $12 Price Target

BenzingaSep 16 07:28 ET

Piper Sandler Sticks to Its Buy Rating for IO Biotech (IOBT)

TipRanksSep 16 06:59 ET

Buy Rating for IO Biotech Backed by Promising ESMO Data and Superior Efficacy of IO102-IO103 Combination Therapy

TipRanksSep 16 06:27 ET

Morgan Stanley Maintains IO Biotech(IOBT.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsSep 9 16:32 ET

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and IO Biotech (IOBT)

TipRanksSep 5 08:22 ET

Morgan Stanley Maintains IO Biotech(IOBT.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsSep 3 08:33 ET

IO Biotech Analyst Ratings

BenzingaSep 3 06:59 ET

H.C. Wainwright Maintains IO Biotech(IOBT.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsSep 3 06:33 ET

Morgan Stanley Maintains IO Biotech(IOBT.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsSep 3 05:32 ET

Morgan Stanley Maintains IO Biotech(IOBT.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsAug 14 09:31 ET

IO Biotech Analyst Ratings

BenzingaAug 14 07:58 ET

Morgan Stanley Maintains IO Biotech(IOBT.US) With Buy Rating, Announces Target Price $7

Moomoo NewsAug 14 07:34 ET